{'fraction_non_alphanumeric': 0.02318840579710145, 'fraction_numerical': 0.0, 'mean_word_length': 5.281818181818182, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Serum Hepatitis B Virus RNA as a Potential Diagnostic Biomarker During Chronic Hepatitis B Virus Infection

Clinicians rely on hepatitis B virus (HBV) biomarkers in patient serum to monitor infection in the liver. Serum HBV DNA is used to track viral replication within infected hepatocytes. Development of antibodies to HBV surface antigen (HBsAg) and the secreted e antigen (HBeAg) mark important immune control milestones and inform treatment decisions in chronic HBV (CHB) infections. Recently, it has been appreciated that HBV pregenomic RNA (pgRNA) is also found in serum; the potential relevance of pgRNA as a biomarker during CHB infection is currently the subject of investigation.